Compare Williams Companies Inc (WMB) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Williams Companies Inc vs Zoetis Inc — how do they compare? Williams Companies Inc trades at $75.42 (market cap $92.75B), while Zoetis Inc trades at $73.51 (market cap $30.40B). The key difference: Williams Companies Inc is far larger — about 3.1× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.88%). Which is the better fit depends on your goals.
| WMB | ZTS | |
|---|---|---|
Market Cap | $92.75B | $30.40B |
Sector | Energy | Health |
52-Week High | $79.40 | $150.61 |
52-Week Low | $56.51 | $71.91 |
Enterprise Value | $123.38B | $37.96B |
Dividend Yield | 2.77% | 2.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Williams Companies (WMB) trades at $75.83, up 2.27% with strong analyst support (79% buy ratings) and a $88.14 consensus target. The stock shows bullish technical momentum above key support at $74, supported by recent acquisitions and stable dividend payments. Fundamentals reveal robust profitability with 63.26% gross margins and 25.18% net income margin, though valuation multiples remain elevated with P/E at 30.21.
WMB offers exposure to growing natural gas infrastructure demand with recent $5.5 billion Momentum Midstream acquisition expanding Gulf Coast presence. Risks include regulatory challenges as seen with NJ pipeline permit reversal and elevated debt levels at 52% debt-to-asset ratio. The stock presents growth potential through LNG export expansion but faces execution risks on major projects.
Zoetis (ZTS) trades at $73.60, down 2.92% amid bearish technical signals and mixed earnings. The stock faces pressure from weakening U.S. companion animal sales and competitive headwinds, though profitability remains strong with 71.67% gross margins and 27.69% net income margin. Recent Q2 2026 earnings beat estimates but revenue missed, prompting a guidance cut. Analyst consensus is divided with 45% Buy ratings and a $93.40 price target, suggesting 27% upside from current levels.
The outlook balances valuation appeal (P/E of 12) against near-term operational challenges. Investment opportunity lies in market dominance and robust cash flow generation, while risks include sustained pet health demand softness and competitive pricing pressure. The stock trades near support at $73, with institutional sentiment mixed amid recent portfolio adjustments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
